Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study

Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study

Background: Eradication of hepatitis C virus (HCV) promotes an improvement in liver disease and the deactivation of the immune system. Here, we aimed to evaluate the changes in liver disease scores and plasma biomarkers following HCV clearance with direct-acting antivirals (DAAs) in HIV-infected pat...

Full description

Bibliographic Details
Main Authors: Luz Maria Medrano, Juan Berenguer, Sergio Salgüero, Juan González-García, Cristina Díez, Víctor Hontañón, Pilar Garcia-Broncano, Luis Ibañez-Samaniego, José M. Bellón, María Angeles Jiménez-Sousa, Salvador Resino
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Medicine
Subjects:
chronic hepatitis C (CHC)
direct-acting antiviral (DAA) therapy
HIV/HCV co-infected patients
cirrhosis
inflammation
coagulopathy
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.615342/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.615342/full

Similar Items